# Apogee Therapeutics, Inc. – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/apogee-therapeutics-inc
Company JSON: https://spela.port0.org/company/apogee-therapeutics-inc/company.json
Documents JSON: https://spela.port0.org/company/apogee-therapeutics-inc/documents.json
Updated: 2026-08-06T08:08:36Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/apogee-therapeutics-inc/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/apogee-therapeutics-inc/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/apogee-therapeutics-inc/market/manifest.json
- SEC Company Facts JSON: https://spela.port0.org/company/apogee-therapeutics-inc/market/sec-companyfacts.json
- SEC filing-manifest JSON: https://spela.port0.org/company/apogee-therapeutics-inc/market/sec-manifest.json
- SEC sammanfattning JSON: https://spela.port0.org/company/apogee-therapeutics-inc/market/sec-summary.json

## Full-text source documents
- SEC EDGAR | 8-K – 2026-06-22 – ef20076542_8k.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-06-22 – ef20076505_8k.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-06-12 – apge-20260609.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-05-27 – tm2615568d2_8k.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-05-27 – tm2615568d1_8k.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-05-11 – apge-20260511.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm/fulltext.txt
- SEC EDGAR | 10-Q – 2026-05-11 – apge-20260331.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-002.html
  - HTML part 3: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-003.html
- SEC EDGAR | 8-K – 2026-04-24 – apge-20260421.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-03-25 – tm269761d1_8k.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-03-23 – tm269553d1_8k.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-03-02 – apge-20260302.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm/fulltext.txt
- SEC EDGAR | 10-K – 2026-03-02 – apge-20251231.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-002.html
  - HTML part 3: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-003.html
  - HTML part 4: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-004.html
- SEC EDGAR | 8-K – 2026-01-06 – tm261950d1_8k.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-11-10 – apge-20251110.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm/fulltext.txt
- SEC EDGAR | 10-Q – 2025-11-10 – apge-20250930.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-002.html
  - HTML part 3: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-003.html
- SEC EDGAR | 8-K – 2025-10-10 – tm2528385d1_8k.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-08-11 – apge-20250811.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm/fulltext.txt
- SEC EDGAR | 10-Q – 2025-08-11 – apge-20250630.htm: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-002.html
  - HTML part 3: https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-003.html